Yuanzhi-1

N/A

Report date: 2022/12/07 16:06:55

Base Information

Drug NameYuanzhi-1
Drug Alias NameA triterpenoid saponin derived from the dried root of Polygala tenuifolia Willd（Capital Medical University）Yuanzhi-1
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionSerotonin reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsSerotonin transporterNorepinephrine transporter
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCapital Medical University
China Registration ClassN/A

Develop Information

Active CompaniesCapital Medical University
Inactive CompaniesN/A
Active IndicationsDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A